ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer
German Journal of Pharmaceuticals and Biomaterials · 2022
DOI: 10.5530/gjpb.2022.3.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift German Journal of Pharmaceuticals and Biomaterials, 2022. Verfasst von Rachel Cordeiro und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cordeiro, R., Khan, S., Tajir, H., Bagwan, A., Shaikh, M. A., & Gupta, A. (2022). ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer. German Journal of Pharmaceuticals and Biomaterials. https://doi.org/10.5530/gjpb.2022.3.12
Vancouver
Cordeiro R, Khan S, Tajir H, Bagwan A, Shaikh MA, Gupta A. ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer. German Journal of Pharmaceuticals and Biomaterials. 2022. doi:10.5530/gjpb.2022.3.12
BibTeX
@article{Cordeiro2022,
author = {Cordeiro, Rachel and Khan, Saba and Tajir, Heena and Bagwan, Afsha and Shaikh, Mohd Anas and Gupta, Ashish},
title = {ADMET Prediction of synthesized Heterocyclic derivatives to treat renal cancer},
journal = {German Journal of Pharmaceuticals and Biomaterials},
year = {2022},
doi = {10.5530/gjpb.2022.3.12}
}
EUVIMED